

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.12631290 |
| 2 | negative regulation of cell killing (GO:0031342) | 7.12631290 |
| 3 | response to muramyl dipeptide (GO:0032495) | 4.51165214 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.43890061 |
| 5 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.20174452 |
| 6 | response to peptidoglycan (GO:0032494) | 3.92466845 |
| 7 | macroautophagy (GO:0016236) | 3.81170510 |
| 8 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.79165168 |
| 9 | positive regulation of heat generation (GO:0031652) | 3.77225154 |
| 10 | activated T cell proliferation (GO:0050798) | 3.65453954 |
| 11 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.55372836 |
| 12 | germinal center formation (GO:0002467) | 3.52332417 |
| 13 | response to interleukin-15 (GO:0070672) | 3.52134461 |
| 14 | NIK/NF-kappaB signaling (GO:0038061) | 3.47270002 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46223265 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 3.44471379 |
| 17 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.44463384 |
| 18 | alkaloid metabolic process (GO:0009820) | 3.38845720 |
| 19 | histone H3-K4 trimethylation (GO:0080182) | 3.35791780 |
| 20 | histone H3-K9 modification (GO:0061647) | 3.35520705 |
| 21 | histone H3-K36 demethylation (GO:0070544) | 3.35162144 |
| 22 | mannose metabolic process (GO:0006013) | 3.34591240 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.31708205 |
| 24 | phenylpropanoid metabolic process (GO:0009698) | 3.30394755 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.29648477 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.27215988 |
| 27 | negative thymic T cell selection (GO:0045060) | 3.25604958 |
| 28 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.25187664 |
| 29 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.25187664 |
| 30 | positive regulation of bone resorption (GO:0045780) | 3.21384129 |
| 31 | positive regulation of bone remodeling (GO:0046852) | 3.21384129 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.20116590 |
| 33 | regulation of immunoglobulin secretion (GO:0051023) | 3.17956361 |
| 34 | histone H3-K9 methylation (GO:0051567) | 3.14091555 |
| 35 | negative T cell selection (GO:0043383) | 3.07093466 |
| 36 | positive regulation of granulocyte differentiation (GO:0030854) | 3.07038472 |
| 37 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.04332866 |
| 38 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.03879854 |
| 39 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.03879854 |
| 40 | alanine transport (GO:0032328) | 3.00339205 |
| 41 | tolerance induction (GO:0002507) | 2.98453979 |
| 42 | negative regulation of innate immune response (GO:0045824) | 2.94544738 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93502320 |
| 44 | B cell homeostasis (GO:0001782) | 2.90260037 |
| 45 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.90254717 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 2.89730697 |
| 47 | regulation of fever generation (GO:0031620) | 2.88351280 |
| 48 | T cell proliferation (GO:0042098) | 2.82449432 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 2.81972716 |
| 50 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.80701604 |
| 51 | negative regulation of B cell mediated immunity (GO:0002713) | 2.80701604 |
| 52 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78987108 |
| 53 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.75357328 |
| 54 | protein carboxylation (GO:0018214) | 2.75357328 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 2.75184924 |
| 56 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.73141268 |
| 57 | leukocyte aggregation (GO:0070486) | 2.72397792 |
| 58 | regulation of heat generation (GO:0031650) | 2.69093945 |
| 59 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.67353266 |
| 60 | pyrimidine dimer repair (GO:0006290) | 2.66791678 |
| 61 | negative regulation of type 2 immune response (GO:0002829) | 2.65646862 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.64068495 |
| 63 | positive regulation of B cell proliferation (GO:0030890) | 2.63041746 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.62796516 |
| 65 | regulation of fibrinolysis (GO:0051917) | 2.62398780 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 2.62223088 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62223088 |
| 68 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62223088 |
| 69 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62223088 |
| 70 | modulation by symbiont of host immune response (GO:0052553) | 2.62223088 |
| 71 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62223088 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 2.62109201 |
| 73 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.61583294 |
| 74 | thymic T cell selection (GO:0045061) | 2.60908013 |
| 75 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.59876384 |
| 76 | regulation of ARF protein signal transduction (GO:0032012) | 2.58385434 |
| 77 | T cell homeostasis (GO:0043029) | 2.58043345 |
| 78 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.56886088 |
| 79 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.56628093 |
| 80 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.55035224 |
| 81 | activation of JUN kinase activity (GO:0007257) | 2.53642855 |
| 82 | T cell selection (GO:0045058) | 2.52802005 |
| 83 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.52564551 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 2.52538868 |
| 85 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51146358 |
| 86 | neutrophil activation (GO:0042119) | 2.50767065 |
| 87 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.49362657 |
| 88 | histone H3-K9 demethylation (GO:0033169) | 2.49162047 |
| 89 | histone lysine demethylation (GO:0070076) | 2.48692748 |
| 90 | regulation of granulocyte differentiation (GO:0030852) | 2.48143615 |
| 91 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47494310 |
| 92 | positive T cell selection (GO:0043368) | 2.45362892 |
| 93 | histone demethylation (GO:0016577) | 2.43587836 |
| 94 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.42426455 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.42391619 |
| 96 | histone H3-K4 methylation (GO:0051568) | 2.40961843 |
| 97 | positive regulation of T cell chemotaxis (GO:0010820) | 2.40905670 |
| 98 | regulation of T cell chemotaxis (GO:0010819) | 2.40905670 |
| 99 | positive thymic T cell selection (GO:0045059) | 2.40764503 |
| 100 | T-helper cell differentiation (GO:0042093) | 2.40623254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.31848773 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29270014 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.28392630 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.00912213 |
| 5 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.77766867 |
| 6 | MAF_26560356_Chip-Seq_TH1_Human | 2.72255619 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.69338510 |
| 8 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.61124564 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.56143380 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50180609 |
| 11 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.43820271 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.43166526 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.41728413 |
| 14 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.37386225 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.36608902 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.32606917 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.31777238 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.29165778 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.27709006 |
| 20 | MAF_26560356_Chip-Seq_TH2_Human | 2.27242839 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.26383371 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20352821 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.18997773 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.11375938 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10237918 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.06653306 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.02237202 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93362750 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90664485 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87729365 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82625233 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.81819915 |
| 33 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.80728521 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78695198 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76557923 |
| 36 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.73774683 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72971392 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71854834 |
| 39 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.69365038 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.67487149 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63059146 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.60150876 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59615953 |
| 44 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.58141340 |
| 45 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.57845236 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56936204 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55948014 |
| 48 | P68_20966046_ChIP-Seq_HELA_Human | 1.55853888 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.49072951 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.45247542 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.44816879 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43341795 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43072409 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42841450 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41501221 |
| 56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40689998 |
| 57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40395712 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40362113 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36503194 |
| 60 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33876113 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32613712 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31505598 |
| 63 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30926091 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28779758 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28116964 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28079302 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25597781 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25499446 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25363643 |
| 70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24248109 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24128610 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22849121 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22483677 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19376847 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17737329 |
| 76 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16617731 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16026321 |
| 78 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14976805 |
| 79 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14092594 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11954514 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11041103 |
| 82 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10157172 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10137158 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08347333 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07382047 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07333229 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07322627 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06901514 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05912539 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 1.05306784 |
| 91 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.02924067 |
| 92 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01775418 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01578872 |
| 94 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01407565 |
| 95 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00887721 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99683096 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99506673 |
| 98 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.99306717 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99044194 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98152722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.43544967 |
| 2 | MP0000685_abnormal_immune_system | 3.36931748 |
| 3 | MP0005360_urolithiasis | 3.34630779 |
| 4 | MP0003303_peritoneal_inflammation | 3.21066761 |
| 5 | MP0003724_increased_susceptibility_to | 2.95237474 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.61453993 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.58810199 |
| 8 | MP0001986_abnormal_taste_sensitivity | 2.55828764 |
| 9 | MP0001790_abnormal_immune_system | 2.46431352 |
| 10 | MP0005387_immune_system_phenotype | 2.46431352 |
| 11 | MP0001800_abnormal_humoral_immune | 2.46000812 |
| 12 | MP0003787_abnormal_imprinting | 2.33829719 |
| 13 | MP0001873_stomach_inflammation | 2.30078280 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.25249033 |
| 15 | MP0002723_abnormal_immune_serum | 2.17943682 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.07913241 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.01141464 |
| 18 | MP0005671_abnormal_response_to | 1.99670763 |
| 19 | MP0005025_abnormal_response_to | 1.97680764 |
| 20 | MP0002420_abnormal_adaptive_immunity | 1.94269611 |
| 21 | MP0001819_abnormal_immune_cell | 1.92216098 |
| 22 | MP0002419_abnormal_innate_immunity | 1.87364226 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.85062599 |
| 24 | MP0002396_abnormal_hematopoietic_system | 1.84783385 |
| 25 | MP0002009_preneoplasia | 1.84323193 |
| 26 | MP0002398_abnormal_bone_marrow | 1.83196704 |
| 27 | MP0000703_abnormal_thymus_morphology | 1.82594624 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.80395187 |
| 29 | MP0000716_abnormal_immune_system | 1.80302332 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.76255930 |
| 31 | MP0004381_abnormal_hair_follicle | 1.69028173 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.65446728 |
| 33 | MP0005365_abnormal_bile_salt | 1.63753005 |
| 34 | MP0004947_skin_inflammation | 1.62332472 |
| 35 | MP0005423_abnormal_somatic_nervous | 1.61589405 |
| 36 | MP0001348_abnormal_lacrimal_gland | 1.60218188 |
| 37 | MP0002254_reproductive_system_inflammat | 1.59103545 |
| 38 | MP0005451_abnormal_body_composition | 1.58670500 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.58173430 |
| 40 | MP0003195_calcinosis | 1.56255275 |
| 41 | MP0008057_abnormal_DNA_replication | 1.50576721 |
| 42 | MP0002405_respiratory_system_inflammati | 1.48023223 |
| 43 | MP0002722_abnormal_immune_system | 1.47089280 |
| 44 | MP0005409_darkened_coat_color | 1.46584555 |
| 45 | MP0001915_intracranial_hemorrhage | 1.46316454 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.43292462 |
| 47 | MP0002429_abnormal_blood_cell | 1.40885980 |
| 48 | MP0009278_abnormal_bone_marrow | 1.39774159 |
| 49 | MP0003868_abnormal_feces_composition | 1.38363287 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.38197325 |
| 51 | MP0003866_abnormal_defecation | 1.38134669 |
| 52 | MP0006082_CNS_inflammation | 1.35092155 |
| 53 | MP0008995_early_reproductive_senescence | 1.28512798 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.27853158 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.25431406 |
| 56 | MP0003786_premature_aging | 1.23403978 |
| 57 | MP0005310_abnormal_salivary_gland | 1.21794684 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.19413425 |
| 59 | MP0009785_altered_susceptibility_to | 1.15306162 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.14584453 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.14452421 |
| 62 | MP0009840_abnormal_foam_cell | 1.12130237 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.10449459 |
| 64 | MP0002933_joint_inflammation | 1.09939205 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.08598914 |
| 66 | MP0008469_abnormal_protein_level | 1.07023290 |
| 67 | MP0009764_decreased_sensitivity_to | 1.07006523 |
| 68 | MP0003252_abnormal_bile_duct | 1.06702915 |
| 69 | MP0004142_abnormal_muscle_tone | 1.06414263 |
| 70 | MP0008961_abnormal_basal_metabolism | 1.06344515 |
| 71 | MP0000003_abnormal_adipose_tissue | 0.99667053 |
| 72 | MP0003959_abnormal_lean_body | 0.99292215 |
| 73 | MP0008877_abnormal_DNA_methylation | 0.97570264 |
| 74 | MP0000609_abnormal_liver_physiology | 0.96455181 |
| 75 | MP0001853_heart_inflammation | 0.96075057 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.94178376 |
| 77 | MP0003122_maternal_imprinting | 0.93906892 |
| 78 | MP0009115_abnormal_fat_cell | 0.93762962 |
| 79 | MP0004043_abnormal_pH_regulation | 0.90091345 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.87954546 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 0.87770698 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 0.87518272 |
| 83 | MP0000604_amyloidosis | 0.85012225 |
| 84 | MP0010329_abnormal_lipoprotein_level | 0.82423483 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.80664716 |
| 86 | MP0002118_abnormal_lipid_homeostasis | 0.80478099 |
| 87 | MP0003279_aneurysm | 0.79676587 |
| 88 | MP0009384_cardiac_valve_regurgitation | 0.79561880 |
| 89 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79063644 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.78357836 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.77895349 |
| 92 | MP0005647_abnormal_sex_gland | 0.75190284 |
| 93 | MP0005535_abnormal_body_temperature | 0.74912235 |
| 94 | MP0003121_genomic_imprinting | 0.73354213 |
| 95 | MP0002089_abnormal_postnatal_growth/wei | 0.70078288 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.69639046 |
| 97 | MP0003045_fibrosis | 0.67262911 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.66354880 |
| 99 | MP0002970_abnormal_white_adipose | 0.65811966 |
| 100 | MP0001188_hyperpigmentation | 0.65502937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.12752703 |
| 2 | Recurrent cutaneous fungal infections (HP:0011370) | 5.12752703 |
| 3 | Persistence of primary teeth (HP:0006335) | 4.51796935 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.25847632 |
| 5 | Abnormal tarsal ossification (HP:0008369) | 3.77433076 |
| 6 | Increased density of long bones (HP:0006392) | 3.64959339 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52949508 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.43623447 |
| 9 | Anteriorly placed anus (HP:0001545) | 3.28220178 |
| 10 | Hemorrhage of the eye (HP:0011885) | 3.14935809 |
| 11 | Abnormality of carpal bone ossification (HP:0006257) | 3.12011772 |
| 12 | Genetic anticipation (HP:0003743) | 3.04310668 |
| 13 | Cheilitis (HP:0100825) | 2.97043262 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 2.94917623 |
| 15 | Recurrent skin infections (HP:0001581) | 2.93686846 |
| 16 | Poikiloderma (HP:0001029) | 2.92734911 |
| 17 | Eczematoid dermatitis (HP:0000976) | 2.92413296 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 2.89996534 |
| 19 | Flat acetabular roof (HP:0003180) | 2.88689829 |
| 20 | Thin bony cortex (HP:0002753) | 2.83144631 |
| 21 | Joint hemorrhage (HP:0005261) | 2.81103009 |
| 22 | Absent speech (HP:0001344) | 2.75363484 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.66693660 |
| 24 | Abnormal foot bone ossification (HP:0010675) | 2.65499877 |
| 25 | Abnormality of the fingertips (HP:0001211) | 2.61661553 |
| 26 | Pustule (HP:0200039) | 2.57586596 |
| 27 | Meningitis (HP:0001287) | 2.56773630 |
| 28 | Large eyes (HP:0001090) | 2.56036127 |
| 29 | Colitis (HP:0002583) | 2.55292373 |
| 30 | Basal cell carcinoma (HP:0002671) | 2.54584048 |
| 31 | Abnormal ossification of hand bones (HP:0005921) | 2.50285666 |
| 32 | Myositis (HP:0100614) | 2.47263261 |
| 33 | Hyperacusis (HP:0010780) | 2.46094664 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.44969328 |
| 35 | Premature loss of primary teeth (HP:0006323) | 2.44840208 |
| 36 | Supernumerary nipples (HP:0002558) | 2.40673857 |
| 37 | Broad face (HP:0000283) | 2.40614602 |
| 38 | Pulmonary embolism (HP:0002204) | 2.40187161 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.35434235 |
| 40 | Increased IgE level (HP:0003212) | 2.35408161 |
| 41 | Optic neuritis (HP:0100653) | 2.32749140 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 2.32749140 |
| 43 | Abnormality of the columella (HP:0009929) | 2.30498732 |
| 44 | Slow saccadic eye movements (HP:0000514) | 2.29666741 |
| 45 | Orchitis (HP:0100796) | 2.26741047 |
| 46 | Long palpebral fissure (HP:0000637) | 2.25161285 |
| 47 | Abnormal hand bone ossification (HP:0010660) | 2.24974867 |
| 48 | Tented upper lip vermilion (HP:0010804) | 2.23854800 |
| 49 | Gingival bleeding (HP:0000225) | 2.23183317 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.21976070 |
| 51 | Squamous cell carcinoma (HP:0002860) | 2.18752476 |
| 52 | Supranuclear gaze palsy (HP:0000605) | 2.17689145 |
| 53 | Neonatal respiratory distress (HP:0002643) | 2.12979254 |
| 54 | Prolonged partial thromboplastin time (HP:0003645) | 2.11027703 |
| 55 | T lymphocytopenia (HP:0005403) | 2.08941870 |
| 56 | Inflammation of the large intestine (HP:0002037) | 2.08899184 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.08255705 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.07304227 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05751036 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.04136026 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.03689708 |
| 62 | Neuronal loss in central nervous system (HP:0002529) | 2.01982630 |
| 63 | Urticaria (HP:0001025) | 2.01017958 |
| 64 | Elevated alkaline phosphatase (HP:0003155) | 2.00361986 |
| 65 | Entropion (HP:0000621) | 1.99615665 |
| 66 | Abnormality of T cell number (HP:0011839) | 1.99309137 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96055870 |
| 68 | Mucopolysacchariduria (HP:0008155) | 1.96055870 |
| 69 | Bile duct proliferation (HP:0001408) | 1.95164499 |
| 70 | Abnormal biliary tract physiology (HP:0012439) | 1.95164499 |
| 71 | Fetal akinesia sequence (HP:0001989) | 1.93701773 |
| 72 | Obstructive lung disease (HP:0006536) | 1.93331968 |
| 73 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93331968 |
| 74 | Hemoptysis (HP:0002105) | 1.92702158 |
| 75 | Diplopia (HP:0000651) | 1.92303400 |
| 76 | Abnormality of binocular vision (HP:0011514) | 1.92303400 |
| 77 | IgG deficiency (HP:0004315) | 1.91823110 |
| 78 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.91541032 |
| 79 | Dislocated radial head (HP:0003083) | 1.91281743 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91144155 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91144155 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91144155 |
| 83 | Ectropion (HP:0000656) | 1.89963710 |
| 84 | Encephalitis (HP:0002383) | 1.89862757 |
| 85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.88379514 |
| 86 | Agammaglobulinemia (HP:0004432) | 1.87498735 |
| 87 | Increased serum ferritin (HP:0003281) | 1.87261749 |
| 88 | Obstructive sleep apnea (HP:0002870) | 1.86762680 |
| 89 | Hypophosphatemia (HP:0002148) | 1.84410490 |
| 90 | Recurrent abscess formation (HP:0002722) | 1.84183961 |
| 91 | Hypochromic anemia (HP:0001931) | 1.83356838 |
| 92 | Xanthomatosis (HP:0000991) | 1.83125613 |
| 93 | Keratitis (HP:0000491) | 1.82848368 |
| 94 | Viral hepatitis (HP:0006562) | 1.82006414 |
| 95 | Recurrent viral infections (HP:0004429) | 1.81569717 |
| 96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.77983419 |
| 97 | Plagiocephaly (HP:0001357) | 1.77796515 |
| 98 | Abnormality of vision evoked potentials (HP:0000649) | 1.77438747 |
| 99 | Chronic hepatic failure (HP:0100626) | 1.77101721 |
| 100 | Vasculitis (HP:0002633) | 1.75743792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK2 | 3.23556103 |
| 2 | MAP4K1 | 2.88206862 |
| 3 | TRIB3 | 2.68583155 |
| 4 | PRPF4B | 2.67372807 |
| 5 | SIK3 | 2.55114156 |
| 6 | SIK1 | 2.45821745 |
| 7 | MAP3K14 | 2.01456856 |
| 8 | CDK12 | 2.00151401 |
| 9 | FGFR4 | 1.97394611 |
| 10 | MARK2 | 1.96343773 |
| 11 | FES | 1.87286470 |
| 12 | ERN1 | 1.84642466 |
| 13 | CDC42BPA | 1.81267035 |
| 14 | TNK2 | 1.80448243 |
| 15 | BLK | 1.80282698 |
| 16 | IKBKE | 1.74050429 |
| 17 | TYK2 | 1.70228983 |
| 18 | RIPK4 | 1.66747093 |
| 19 | MAP3K10 | 1.56854147 |
| 20 | TAOK1 | 1.55414131 |
| 21 | GRK6 | 1.48282919 |
| 22 | TESK2 | 1.48270439 |
| 23 | CSF1R | 1.42792202 |
| 24 | JAK3 | 1.39009942 |
| 25 | IKBKB | 1.37402095 |
| 26 | BTK | 1.35401760 |
| 27 | TXK | 1.34417714 |
| 28 | FGR | 1.34093904 |
| 29 | LIMK1 | 1.33555214 |
| 30 | IRAK4 | 1.31013067 |
| 31 | MAP3K7 | 1.30418192 |
| 32 | CAMKK1 | 1.25474594 |
| 33 | MAP2K3 | 1.25342766 |
| 34 | SYK | 1.25175734 |
| 35 | TBK1 | 1.24052869 |
| 36 | NME1 | 1.23754140 |
| 37 | JAK1 | 1.21315526 |
| 38 | IRAK2 | 1.17764036 |
| 39 | MAPK12 | 1.15885249 |
| 40 | ZAP70 | 1.15119266 |
| 41 | ICK | 1.14431079 |
| 42 | PRKD2 | 1.09943928 |
| 43 | TLK1 | 1.09279086 |
| 44 | WNK4 | 0.98947215 |
| 45 | RPS6KA2 | 0.95454040 |
| 46 | GRK7 | 0.94767673 |
| 47 | BMPR2 | 0.93851999 |
| 48 | SMG1 | 0.93699910 |
| 49 | FGFR3 | 0.93228185 |
| 50 | HCK | 0.92932192 |
| 51 | WNK1 | 0.91692612 |
| 52 | MAP3K6 | 0.91387408 |
| 53 | EPHB1 | 0.88211700 |
| 54 | CDK9 | 0.85688377 |
| 55 | MAP3K11 | 0.85627764 |
| 56 | KSR2 | 0.85567841 |
| 57 | LYN | 0.84997665 |
| 58 | LCK | 0.84086677 |
| 59 | CHUK | 0.83834528 |
| 60 | DYRK3 | 0.83787664 |
| 61 | CDK4 | 0.80252071 |
| 62 | CAMK4 | 0.77675990 |
| 63 | DYRK1B | 0.76098986 |
| 64 | CSK | 0.75181165 |
| 65 | SGK3 | 0.75049491 |
| 66 | MAP3K1 | 0.74396930 |
| 67 | MAP3K13 | 0.72111137 |
| 68 | EEF2K | 0.70779613 |
| 69 | MAPK13 | 0.69748396 |
| 70 | SGK2 | 0.69704797 |
| 71 | MARK1 | 0.69389296 |
| 72 | MAPK11 | 0.69337853 |
| 73 | CCNB1 | 0.68899193 |
| 74 | EPHA3 | 0.67733387 |
| 75 | BCR | 0.67664638 |
| 76 | ITK | 0.67644134 |
| 77 | CAMK1D | 0.67089181 |
| 78 | MAPK7 | 0.65006375 |
| 79 | PRKCH | 0.64541290 |
| 80 | UHMK1 | 0.64491814 |
| 81 | NEK9 | 0.63460026 |
| 82 | MATK | 0.62452066 |
| 83 | DAPK2 | 0.62283193 |
| 84 | PINK1 | 0.60662483 |
| 85 | TYRO3 | 0.59080805 |
| 86 | MAP2K6 | 0.58087176 |
| 87 | SGK494 | 0.57378890 |
| 88 | SGK223 | 0.57378890 |
| 89 | MAP2K4 | 0.54834911 |
| 90 | MTOR | 0.54456998 |
| 91 | RET | 0.54383576 |
| 92 | AKT3 | 0.53821040 |
| 93 | BRD4 | 0.53547463 |
| 94 | MAPK15 | 0.52407543 |
| 95 | IRAK1 | 0.52109533 |
| 96 | PRKCZ | 0.52107283 |
| 97 | MARK3 | 0.51576372 |
| 98 | STK38 | 0.49432672 |
| 99 | KIT | 0.48523208 |
| 100 | PDK1 | 0.46205252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.81191971 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33587420 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.29879022 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.19068130 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.17822915 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.98507392 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96798985 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80558872 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.78907379 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78737581 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73736078 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70498992 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59467998 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.56755258 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.55862377 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54062488 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53092250 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49385009 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43163922 |
| 20 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.43032521 |
| 21 | Hepatitis B_Homo sapiens_hsa05161 | 1.42189952 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.41617198 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.35135410 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.27385050 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24160101 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21382156 |
| 27 | Hepatitis C_Homo sapiens_hsa05160 | 1.21168899 |
| 28 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19953752 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.19809479 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18369635 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14197795 |
| 32 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13703342 |
| 33 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11503804 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.11021384 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06748339 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04396363 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04364727 |
| 38 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00770987 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00413263 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98704710 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98529748 |
| 42 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98101505 |
| 43 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97293524 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 0.95605127 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92987717 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92908224 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92283897 |
| 48 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92255811 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90048598 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.89671055 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88192566 |
| 52 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86998038 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83032023 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82423951 |
| 55 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81425805 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.80248404 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78517513 |
| 58 | Prostate cancer_Homo sapiens_hsa05215 | 0.77386878 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76154069 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.75348253 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75274573 |
| 62 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74965158 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74849825 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73441106 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73228081 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71899944 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71365838 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71096005 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69164695 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69000780 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68988997 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.67234468 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.65292846 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64137342 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63985687 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62269177 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61404291 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.60597248 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60145990 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.57151408 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56981292 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56945265 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56629233 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56297239 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56081561 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55520324 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55104551 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54632117 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53578780 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52897558 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.50559628 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.49428480 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48078693 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47477688 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47405811 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46999443 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46712744 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45704245 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44341676 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.43739357 |

